Paper41350795
Research progress on carcinogenic factors and personalized treatment of oral cancer.
Xu K and 6 others. Discov Oncol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Research progress on carcinogenic factors and personalized treatment of oral cancer. Papers, record 41350795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41350795
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RC230088 | Shenyang Young and Middle aged Science and Technology Talents Cultivation Special Project for Returning Overseas Youth | PubMed | ||
| 2024-BS-280 | Doctoral Research Start-up Projects of the Natural Science Foundation of Liaoning Province | PubMed | ||
| LJ222410164030 | Basic Research Projects of Liaoning Provincial Department of Education | PubMed | ||
| (2024JH2/102600237 | Liaoning Provincial Science and Technology Department Science , Technology Plan General Project | PubMed | ||
| LJ222410164024 | Liaoning Provincial Department of Education | PubMed | ||
| No.2025JH2/101900023 | International Industrial Technology Research and Development Project of Liaoning Provincial Department of Science and Technology | PubMed | ||
| 2023JH2/101300079 | )Liaoning Provincial Department of Science and Technology Applied Basic Research Program Project | PubMed |
Source PubMed
References190
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37854901 | Self-negligence and awareness among oral precancerous and cancer patients - A cross-sectional questionnaire study. | J Oral Maxillofac Pathol | 2023 | https://conductscience.org/library/papers/37854901 | PubMed |
| 2 | 36209263 | Tumor microenvironment and immunotherapy of oral cancer. | Eur J Med Res | 2022 | https://conductscience.org/library/papers/36209263 | PubMed |
| 3 | 36299168 | Oncolytic virus preclinical toxicology studies. | J Appl Toxicol | 2023 | https://conductscience.org/library/papers/36299168 | PubMed |
| 4 | 37977279 | A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma - A systematic review. | Mutat Res Rev Mutat Res | 2024 | https://conductscience.org/library/papers/37977279 | PubMed |
| 5 | 37021224 | Synergistic antibacterial effects of 5-fluorouracil or thioridazine in combination with phytopolyphenols on cultured Porphyromonas gingivalis. | J Dent Sci | 2023 | https://conductscience.org/library/papers/37021224 | PubMed |
| 6 | 28110942 | Individualized five-year risk assessment for oral premalignant lesion progression to cancer. | Oral Surg Oral Med Oral Pathol Oral Radiol | 2017 | https://conductscience.org/library/papers/28110942 | PubMed |
| 7 | 39780329 | Efficacy of metformin and verteporfin treatment alone or in combination in a murine head and neck cancer xenograft model. | Eur J Oral Sci | 2025 | https://conductscience.org/library/papers/39780329 | PubMed |
| 8 | 39742703 | The role of ctDNA from liquid biopsy in predicting survival outcomes in HPV-negative head and neck cancer: A meta-analysis. | Oral Oncol | 2025 | https://conductscience.org/library/papers/39742703 | PubMed |
| 9 | 37568595 | The Immune Cells in the Development of Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37568595 | PubMed |
| 10 | 34446473 | Applying the Strategic Planning Process to a Large Research Consortium: The Example of the National Cancer Institute Cohort Consortium. | Cancer Epidemiol Biomarkers Prev | 2021 | https://conductscience.org/library/papers/34446473 | PubMed |
| 11 | 34290920 | Induction Chemotherapy Followed by Radiation Therapy Versus Surgery Followed by Concurrent Chemo-Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Oral Cavity. | Cureus | 2021 | https://conductscience.org/library/papers/34290920 | PubMed |
| 12 | 39695602 | Polyomaviruses and the risk of oral cancer: a systematic review and meta-analysis. | BMC Oral Health | 2024 | https://conductscience.org/library/papers/39695602 | PubMed |
| 13 | 34109128 | Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy. | Front Oncol | 2021 | https://conductscience.org/library/papers/34109128 | PubMed |
| 14 | 29890622 | Liquid Biopsy in Oral Cancer. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29890622 | PubMed |
| 15 | 30031797 | Molecular targeted therapy: Treating cancer with specificity. | Eur J Pharmacol | 2018 | https://conductscience.org/library/papers/30031797 | PubMed |
| 16 | 22877952 | MR assessment of oral cavity carcinomas. | Magn Reson Imaging Clin N Am | 2012 | https://conductscience.org/library/papers/22877952 | PubMed |
| 17 | 38473348 | Classification of Mobile-Based Oral Cancer Images Using the Vision Transformer and the Swin Transformer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473348 | PubMed |
| 18 | 38380036 | Molecular basis, potential biomarkers, and future prospects of OSCC and PD-1/PD-L1 related immunotherapy methods. | Heliyon | 2024 | https://conductscience.org/library/papers/38380036 | PubMed |
| 19 | 35581039 | The Effectiveness of Artificial Intelligence in Detection of Oral Cancer. | Int Dent J | 2022 | https://conductscience.org/library/papers/35581039 | PubMed |
| 20 | 36607434 | Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study. | Support Care Cancer | 2023 | https://conductscience.org/library/papers/36607434 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42353630 | Plant Bioactive Constituents and Their Potential Benefits in HPV-Positive Oropharyngeal Squamous Cell Carcinoma-A Narrative Review. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42353630 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41350795
GET https://conductscience.org/api/papers/v1/41350795/references?page=2